Stock Track | Akero Therapeutics Soars 5.76% on Analyst Upgrade and Optimistic Price Target

Stock Track

2025/01/30

Akero Therapeutics (AKRO) stock soared 5.76% in the intraday trading session on Thursday, following an analyst upgrade and a bullish price target revision.

BofA Securities upgraded Akero Therapeutics to a "Buy" rating from "Neutral" and raised its price target to $63, implying significant upside potential from the current levels. The bullish stance from the analysts fueled optimism among investors, driving the stock higher.

According to analysts polled by FactSet, Akero Therapeutics currently has an average rating of "Buy" and a mean price target of $72.18, suggesting further upside potential for the stock based on analysts' expectations.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1105050309"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105050309\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105050309?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-30 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105050309","market":"us","top_or_hot":-1,"title":"Stock Track | Akero Therapeutics Soars 5.76% on Analyst Upgrade and Optimistic Price Target","media":"Stock Track","content":"<p>Akero Therapeutics (AKRO) stock soared 5.76% in the intraday trading session on Thursday, following an analyst upgrade and a bullish price target revision.</p>\n\n<p>BofA Securities upgraded Akero Therapeutics to a \"Buy\" rating from \"Neutral\" and raised its price target to $63, implying significant upside potential from the current levels. The bullish stance from the analysts fueled optimism among investors, driving the stock higher.</p>\n\n<p>According to analysts polled by FactSet, Akero Therapeutics currently has an average rating of \"Buy\" and a mean price target of $72.18, suggesting further upside potential for the stock based on analysts' expectations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Akero Therapeutics Soars 5.76% on Analyst Upgrade and Optimistic Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Akero Therapeutics Soars 5.76% on Analyst Upgrade and Optimistic Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-30 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Akero Therapeutics (AKRO) stock soared 5.76% in the intraday trading session on Thursday, following an analyst upgrade and a bullish price target revision.</p>\n\n<p>BofA Securities upgraded Akero Therapeutics to a \"Buy\" rating from \"Neutral\" and raised its price target to $63, implying significant upside potential from the current levels. The bullish stance from the analysts fueled optimism among investors, driving the stock higher.</p>\n\n<p>According to analysts polled by FactSet, Akero Therapeutics currently has an average rating of \"Buy\" and a mean price target of $72.18, suggesting further upside potential for the stock based on analysts' expectations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AKRO","symbol_name":"Akero Therapeutics","start_time":0,"source_url":"","article_id":"1105050309","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105050309","pubTimestamp":1738248265,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Akero Therapeutics  stock soared 5.76% in the intraday trading session on Thursday, following an analyst upgrade and a bullish price target revision.BofA Securities upgraded Akero Therapeutics to a \"Buy\" rating from \"Neutral\" and raised its price target to $63, implying significant upside potential from the current levels. The bullish stance from the analysts fueled optimism among investors, driving the stock higher.According to analysts polled by FactSet, Akero Therapeutics currently has an ave","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AKRO":"Akero Therapeutics"},"translate_title":"股票赛道Akero Therapeutics因分析师升级和乐观价格目标而飙升5.76%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKRO":1},"content_text":"Akero Therapeutics (AKRO) stock soared 5.76% in the intraday trading session on Thursday, following an analyst upgrade and a bullish price target revision.\nBofA Securities upgraded Akero Therapeutics to a \"Buy\" rating from \"Neutral\" and raised its price target to $63, implying significant upside potential from the current levels. The bullish stance from the analysts fueled optimism among investors, driving the stock higher.\nAccording to analysts polled by FactSet, Akero Therapeutics currently has an average rating of \"Buy\" and a mean price target of $72.18, suggesting further upside potential for the stock based on analysts' expectations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}